Aloop Therapeutics ApS: Financial statements 2025
CVR: 43257498
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Aloop Therapeutics ApS (CVR 43257498) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -274,227 and a net result of DKK -69,892 compared with DKK -1,295,153 the year before. Equity in the 2025 report amounted to DKK 30,657,300. The solvency ratio was 99.4%.
- Gross Profit
- DKK -274,227
- Profit/Loss
- DKK -69,892
- Equity
- DKK 30,657,300
- Total Assets
- DKK 30,839,334
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -274K | -70K | 30.7M | 0 |
| 2024 | - | -1.3M | -1.3M | 30.7M | - |
| 2023 | - | -9.1M | -8.8M | 32M | 8 |
Official annual report
How creditworthy is Aloop Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Aloop Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -1,323,042, and the net result was DKK -1,295,153.
As of January 22, 2025, Camilla Petrycer Hansen has left the board of directors of Aloop Therapeutics ApS.
As of January 22, 2025, Emmanuelle Coutanceau has left the board of directors of Aloop Therapeutics ApS.
As of January 22, 2025, Rodolphe Clerval is registered as adm. dir. of Aloop Therapeutics ApS.
As of January 22, 2025, Søren Sylvester Skjærbæk has stepped down as adm. dir. of Aloop Therapeutics ApS.
As of January 8, 2025, is registered as an owner of Aloop Therapeutics ApS with an ownership share of 100%.
About Aloop Therapeutics ApS
Aloop Therapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rodolphe Clerval. The company is owned by Coave Therapeutics. The company has 6 employees (2024). In 2025, the company reported a gross profit of DKK -274,227 and a net result of DKK -69,892 compared with DKK -1,295,153 the year before. Equity in the 2025 report amounted to DKK 30,657,300.
